What's in Kringle Pharma, Inc.'s pipeline?

Kringle Pharma, Inc. has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Kringle Pharma, Inc.'s portfolio?

Top competitors by shared drug class: AstraZeneca, GlaxoSmithKline, Daewoong Pharmaceutical Co. LTD., AJU Pharm Co., Ltd., Abbott.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/kringle-pharma-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Kringle Pharma, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Kringle Pharma, Inc. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
KP-100LI	KP-100LI	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
KP-100IT	KP-100IT	phase 3	S1P1 receptor modulator	S1P1	Immunology

Therapeutic area mix

Diabetes · 1
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 2 shared drug classes
GlaxoSmithKline · 2 shared drug classes
Daewoong Pharmaceutical Co. LTD. · 2 shared drug classes
AJU Pharm Co., Ltd. · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
AbbVie · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Kringle Pharma, Inc.:

Cite this brief

Drug Landscape (2026). Kringle Pharma, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/kringle-pharma-inc. Accessed 2026-06-10.